In conclusion, treatment with a TRF from palm oil for four weeks in rats with metabolic syndrome showed significant improvements in blood pressure, cholesterol profile, and systemic antioxidant defense in addition to a reduction in hepatic steatosis, proatherogenic markers such as myeloperoxidase, and proinflammatory markers such as advanced glycation end products. The gene discussed is MPO; the disease is Hepatic steatosis.